コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 is and directing treatment in cases of acute retinal necrosis.
2 ral eye becomes infected and undergoes acute retinal necrosis.
3 e that T cells play a role in development of retinal necrosis.
4 al retina compatible with diagnosis of acute retinal necrosis.
5 e retina, despite initial lack of observable retinal necrosis.
6 Six of 7 specimens had foci of retinal necrosis.
7 gmentation and thinning, iris recession with retinal necrosis and hypotony, a filtering conjunctival
9 arrive in the sensory retina at the onset of retinal necrosis and not during acute retinitis and the
10 al injury, with central sclopetaria retinae, retinal necrosis, and surrounding commotio retinae with
11 etinal whitening without clinically apparent retinal necrosis] and necrotizing retinochoroiditis) at
12 antiviral therapy for the treatment of acute retinal necrosis (ARN) and risk factors impacting visual
14 fy determinants of adverse outcomes in acute retinal necrosis (ARN), presenting characteristics and i
15 simplex virus-type 2 (HSV-2) can cause acute retinal necrosis (ARN), which can lead to exudative and
19 c necrotizing MCMV retinitis (full-thickness retinal necrosis associated with virus inclusions and cy
20 in Sight) Registry Study showing that acute retinal necrosis cases treated with systemic antivirals
24 sensory retina coincident with the onset of retinal necrosis (day 11 p.i.), and CD4+ and CD8+ T cell
25 e considered in the physiopathology of acute retinal necrosis, especially in immunosuppressed patient
26 /6 mice and exhibited absolute resistance to retinal necrosis following subretinal MCMV inoculation,
35 d recurrent lymphocytic meningitis and acute retinal necrosis, we identified two patients heterozygou